Guidance for service providers on the use and management of COVID-19 rapid point of care (near-person) tests and actions to take. Category: UncategorisedBy 1 February 2021Leave a commentPost navigationPreviousPrevious post:Transparency data: PHE prompt payment data: 2020 to 2021NextNext post:Guidance: Investigation of novel SARS-CoV-2 variant: Variant of Concern 202012/01
